IPSC vs JD · rev $6.6M vs P/E 7.6, rev $187.20B
Century Therapeutics Inc (IPSC) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
IPSC currently screens at market cap $47.8M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the IPSC and JD stock pages for the full models.
Not investment advice.